SG11201504951TA - Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine - Google Patents
Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamineInfo
- Publication number
- SG11201504951TA SG11201504951TA SG11201504951TA SG11201504951TA SG11201504951TA SG 11201504951T A SG11201504951T A SG 11201504951TA SG 11201504951T A SG11201504951T A SG 11201504951TA SG 11201504951T A SG11201504951T A SG 11201504951TA SG 11201504951T A SG11201504951T A SG 11201504951TA
- Authority
- SG
- Singapore
- Prior art keywords
- ylamine
- dioxolan
- pyrazol
- ylmethyl
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012087380 | 2012-12-25 | ||
PCT/EP2013/077563 WO2014102164A1 (en) | 2012-12-25 | 2013-12-20 | Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201504951TA true SG11201504951TA (en) | 2015-07-30 |
Family
ID=49876646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201504951TA SG11201504951TA (en) | 2012-12-25 | 2013-12-20 | Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine |
Country Status (24)
Country | Link |
---|---|
US (1) | US9388168B2 (en) |
EP (1) | EP2938609B1 (en) |
JP (1) | JP6297590B2 (en) |
KR (1) | KR102122569B1 (en) |
CN (1) | CN105051031B (en) |
AU (1) | AU2013369473B2 (en) |
BR (1) | BR112015015229B1 (en) |
CA (1) | CA2896155C (en) |
CY (1) | CY1119040T1 (en) |
DK (1) | DK2938609T3 (en) |
ES (1) | ES2629313T3 (en) |
HK (1) | HK1213262A1 (en) |
HR (1) | HRP20170653T1 (en) |
HU (1) | HUE032621T2 (en) |
IL (1) | IL239558A (en) |
LT (1) | LT2938609T (en) |
NZ (1) | NZ709362A (en) |
PL (1) | PL2938609T3 (en) |
PT (1) | PT2938609T (en) |
RU (1) | RU2621725C2 (en) |
SG (1) | SG11201504951TA (en) |
SI (1) | SI2938609T1 (en) |
WO (1) | WO2014102164A1 (en) |
ZA (1) | ZA201504601B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3556354A4 (en) | 2016-12-15 | 2020-07-01 | Hua Medicine (Shanghai) Ltd. | Oral preparation of glucokinase activator and preparation method therefor |
US11813274B2 (en) | 2020-04-22 | 2023-11-14 | Hua Medicine (Shanghai) Ltd. | Treating untreated or treatment-resistant diabetes with glucokinase activator and sodium-glucose cotransporter-2 inhibitor |
AU2020443475A1 (en) * | 2020-04-22 | 2022-11-17 | Hua Medicine (Shanghai) Ltd. | Treating untreated or treatment-resistant diabetes with glucokinase activator and sodium-glucose cotransporter-2 inhibitor |
CN111732543A (en) * | 2020-08-14 | 2020-10-02 | 浙江鼎龙科技有限公司 | Preparation method of 4, 5-diamino-1- (2-hydroxyethyl) pyrazole sulfate |
CN113750100B (en) * | 2021-08-31 | 2022-12-30 | 海南中济医药科技有限公司 | Pharmaceutical composition containing polyagliflozin Ai Ting and sitagliptin and preparation method thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4160841A (en) * | 1977-01-31 | 1979-07-10 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles |
FR2748274B1 (en) * | 1996-05-03 | 1998-06-12 | Oreal | NOVEL DIAMINO PYRAZOLES, SYNTHESIS THEREOF, DYE COMPOSITIONS FOR KERATIN FIBERS CONTAINING THE SAME, METHOD FOR DYEING KERATIN FIBERS |
US8329707B2 (en) | 2008-01-18 | 2012-12-11 | Astellas Pharma Inc. | Substituted pyrazine compounds |
US7741327B2 (en) * | 2008-04-16 | 2010-06-22 | Hoffmann-La Roche Inc. | Pyrrolidinone glucokinase activators |
US8178689B2 (en) * | 2010-06-17 | 2012-05-15 | Hoffman-La Roche Inc. | Tricyclic compounds |
-
2013
- 2013-12-20 JP JP2015550041A patent/JP6297590B2/en active Active
- 2013-12-20 SG SG11201504951TA patent/SG11201504951TA/en unknown
- 2013-12-20 CA CA2896155A patent/CA2896155C/en active Active
- 2013-12-20 PL PL13811542T patent/PL2938609T3/en unknown
- 2013-12-20 BR BR112015015229-5A patent/BR112015015229B1/en active IP Right Grant
- 2013-12-20 RU RU2015126911A patent/RU2621725C2/en active
- 2013-12-20 KR KR1020157019691A patent/KR102122569B1/en active IP Right Grant
- 2013-12-20 CN CN201380068179.8A patent/CN105051031B/en active Active
- 2013-12-20 EP EP13811542.3A patent/EP2938609B1/en active Active
- 2013-12-20 PT PT138115423T patent/PT2938609T/en unknown
- 2013-12-20 AU AU2013369473A patent/AU2013369473B2/en active Active
- 2013-12-20 DK DK13811542.3T patent/DK2938609T3/en active
- 2013-12-20 LT LTEP13811542.3T patent/LT2938609T/en unknown
- 2013-12-20 NZ NZ709362A patent/NZ709362A/en unknown
- 2013-12-20 SI SI201330684A patent/SI2938609T1/en unknown
- 2013-12-20 US US14/655,287 patent/US9388168B2/en active Active
- 2013-12-20 WO PCT/EP2013/077563 patent/WO2014102164A1/en active Application Filing
- 2013-12-20 ES ES13811542.3T patent/ES2629313T3/en active Active
- 2013-12-20 HU HUE13811542A patent/HUE032621T2/en unknown
-
2015
- 2015-06-21 IL IL239558A patent/IL239558A/en active IP Right Grant
- 2015-06-25 ZA ZA2015/04601A patent/ZA201504601B/en unknown
-
2016
- 2016-02-04 HK HK16101337.2A patent/HK1213262A1/en unknown
-
2017
- 2017-04-27 HR HRP20170653TT patent/HRP20170653T1/en unknown
- 2017-07-10 CY CY20171100727T patent/CY1119040T1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20200245T1 (en) | Processes for the preparation of (s)-1-(3-ethoxy-4methoxyphenyl)-2-methanesulfonylethylamine | |
EP2826766A4 (en) | Production method for 2,3,3,3-tetra-fluoropropene | |
HK1206938A1 (en) | Process for the preparation of 3-chloro-4,5,6-trifluoro- picolinonitrile 3--456-- | |
HK1213262A1 (en) | Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h- pyrazol-3-ylamine 1-([13]-4-)-1h--3- | |
EP2840088A4 (en) | Method for preparing 5,6,4'-trihydroxyflavone-7-0-d-glucuronic acid | |
EP2851359A4 (en) | Method for producing 4,4''-dihydroxy-m-terphenyls | |
EP2891647A4 (en) | Method for producing (r)-1,1,3-trimethyl-4-aminoindane | |
IL233938A0 (en) | Process for the preparation of substituted phenylpropanones | |
ZA201503835B (en) | Improved process for the preparation of n-cyano-s[1-(pyridin-3-yl)ethyl]-s-methylsulfilimines | |
HRP20180032T8 (en) | Method for producing 4,4,7-trifluoro-1,2,3,4-tetrahydro-5h-1-benzazepine compound and intermediate for synthesis thereof | |
IL229669A0 (en) | Process for preparation of 1,2,3 -triazole-4-carboxamides | |
PL398065A1 (en) | 1-(dihydroxyphosphoryl)naphthalene-4-(methylphosphonic) acid, process for the preparation of 1-(dihydroxyphosphoryl)naphthalene-4-(methylphosphonic) acid, the use of 1-(dihydroxyphosphoryl)naphthalene-4-(methylphosphonic) acid | |
PL399603A1 (en) | Process for the preparation of 3ß, 15α-dihydroxy-5α-androst-17-one | |
PL392489A1 (en) | Process for the preparation of 3�, 7?-dihydroxy-5?-androst-17-one | |
PL390553A1 (en) | Process for the preparation of 1,2-epoxybutan-3-ol | |
PL390554A1 (en) | Process for the preparation of 2,3-epoxybutan-1-ol | |
IL222929A0 (en) | Process for preparing substituted 1, 3 - dihydro - 2h - indol - 2 - ones |